Who’s allowed to take GLP-1 medications like Ozempic and Mounjaro? Who’s not?
From diabetes, to obesity, to aesthetic purposes, GLP-1 medications have become the newest diet trend.
But with more and more people taking these medications what will the long-term outcomes look like and will there be psychological effects?
Guests:
- Dr. Supatra Tovar, clinical psychologist & registered dietitian
- Dr. W. Scott Butsch, director, Obesity Medicine, Bariatric and Metabolic Institute, Cleveland Clinic
- Dr. Jehangir Ansari, M.D. at med-spa
If you have a disability and would like a transcript or other accommodation you can request an alternative format.